目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的建立治疗性单克隆抗体溶液持续器官灌注模型，应用抗大鼠树突状细胞单克隆抗体(WZD)降低大鼠移植脾的免疫原性。
Objective To reduce immunogenicity of the donor spleen, a rat model of continuous perfusion of graft was established with therapeutic anti dendritic cells monoclonal antibody (WZD).
结论：在中晚期消化道肿瘤，尤其伴有腹水病人治疗中，采用持续腹腔热灌注化疗可明显提高治疗效果。
Conclusions: CHPP on patients with late digestive tract cancer, especially those patients followed by ascites, can evidently enhance the effectiveness of the treatment.
应用推荐